Key facts
- Corthotec’s last known valuation is $2.4M (Jul 2025).
- It has raised $320K; the latest was Later Stage VC ($320K) in Jul 2025.
- Notable investors include Innovate UK, Deep Future.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Corthotec
- ·The full record, as it builds
Funding rounds
No funding rounds for Corthotec are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Corthotec
Developer of a medical device intended to improve the healing of broken bones. The company's device significantly reduces the current need for costly and complicated surgery, alleviating the resulting disability and poor quality of life in those affected, enabling patients with chronic diseases to increase their chances of a positive outcome.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2016
- Employees
- 2
- Website
- corthotec.com/
- Ownership
- Privately Held (backing)
Corthotec doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Corthotec shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Corthotec in its N-PORT filings yet. We sweep new filings monthly.